Pharmaceutical solutions researcher Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI) this morning said its Ovation Science subsidiary has reached a licensing agreement with Cannabiniers, a subsidiary of Lighthouse Strategies, LLC, to distribute Skinvisible’s patented Invisicare transdermal drug-delivery technology to select markets in the United States where medical cannabis products have been legalized.
“We are excited to have Cannabiniers as a partner in the U.S. cannabis market. They are branding experts and have the vision and infrastructure to take Ovation’s cannabis products across the United States,” Skinvisible President Terry Howlett stated in the press release. “Leveraging Cannabiniers branding strategies, we have the ability to enter these markets and provide consumers with an exceptional variety of topical and transdermal products backed by science and formulated with patented technology.”
Read the full article
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Skinvisible (SKVI) Inks Licensing Agreement for Distribution of Topical Cannabis Products in Select U.S. Markets
